Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-039191
Filing Date
2023-11-03
Accepted
2023-11-02 17:51:00
Documents
1
Period of Report
2023-11-02

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 601187
  Complete submission text file 0001493152-23-039191.txt   602197
Mailing Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032
Business Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

EIN.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38630 | Film No.: 231373840
SIC: 2834 Pharmaceutical Preparations